Clinical Trial

Multicenter Prospective Non-randomized Controlled Study of Ella Photodynamic Therapy for Cervical HSIL/CIN2

Study acronym: PDT for CIN2
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates the efficacy and safety of ALA-PDT versus LEEP in treating cervical HSIL/CIN2, aiming to demonstrate non-inferiority in clinical efficacy.
Protocol Amendment History 1 change
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-09
Trial Details
NCT Number NCT07306260
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators: Women's Hospital School Of Medicine Zhejiang University, First People's Hospital of Hangzhou, First Affiliated Hospital of Ningbo University, Shaoxing People's Hospital, Linping First People's Hospital
Conditions HSIL, High Grade Squamous Intraepithelial Lesion, CIN 2, HPV (Human Papillomavirus)-Associated, Photodynamic Therapy (PDT)
Enrollment 560 participants
Start Date 2026-01
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-29